Back

Impact of heart failure unit complexity in the treatment with intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: Insights from the LEVO-D Registry

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Chronic Heart Failure 8 Pharmacotherapy HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor David Dobarro

University Hospital Complex of Vigo, Vigo (Spain)

36 More presentations in this session

Presentation thumbnail
Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure
Doctor M. Vaduganathan (Boston, US)
Abstract Slides
Presentation thumbnail
Guidelines-directed medical treatments in obese vs. non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry
Doctor C. Cappelletto (Trieste, IT)
Abstract Slides
Presentation thumbnail
Hyponatremia in stable patients with advanced heart failure: is the worse prognosis driven by altered hemodynamics?
Miss K. Rask (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Impact of trends in body mass index on outcomes in patients receiving HeartMate 3
Doctor A. daSilva-deAbreu (Rochester, US)
Abstract Slides
Presentation thumbnail
Cardiac magnetic resonance in etiological diagnosis and outcome of heart failure
Doctor J. Vieira (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Chronic Heart Failure 8

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources